
Troxryth S 500mg/250mg Injection
Marketer
Penryth Labs Private Limited
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Troxryth S 500mg/250mg Injection
Combithrox Injection (500mg/250mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thereby limiting infection spread. Administration must be solely under a physician's guidance. Consistent adherence to the prescribed dosage is crucial; premature cessation can compromise treatment effectiveness. Complete the entire course, regardless of symptom improvement. Typical mild side effects may include nausea, vomiting, diarrhea, or indigestion. Severe side effects (e.g., worsening symptoms, allergic reactions such as rash, itching, swelling, or breathing difficulties) necessitate immediate medical attention. Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are vital for optimal recovery. Your physician may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Troxryth S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Troxryth S 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Troxryth S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Troxryth S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Troxryth S 500mg/250mg Injection works:
Troxryth S injection (500mg Ceftriaxone / 250mg Sulbactam) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Troxryth S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Troxryth S (500mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; clinical data from human trials, however, remain scarce.
Breast feedingCAUTION
The administration of Troxryth S 500mg/250mg Injection warrants careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Troxryth S 500mg/250mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Troxryth S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable formulation Troxryth S (500mg/250mg) requires careful administration in individuals with severe hepatic impairment, potentially necessitating dosage modification. Medical advice is recommended. Dosage alteration for Troxryth S (500mg/250mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Troxryth S 500mg/250mg Injection :
Should you inadvertently omit a scheduled dose of Troxryth S 500mg/250mg Injection, seek medical advice from your physician.
Facts to Know About Troxryth S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
